Publication | Closed Access

Berbamine Hydrochloride inhibits lysosomal acidification by activating Nox2 to potentiate chemotherapy-induced apoptosis via the ROS-MAPK pathway in human lung carcinoma cells

OncologyLysosomal AcidificationMedicineOncogenic AgentCell DeathBerbamine HydrochlorideChemotherapy-induced ApoptosisAnti-cancer AgentCancer TreatmentPharmacologyCell BiologyLung CancerCancer Research